Drug Profile
Measles and rubella virus vaccine - Biological E Limited
Alternative Names: MRBEVLatest Information Update: 29 Jan 2020
Price :
$50
*
At a glance
- Originator Biological E Limited
- Class Measles vaccines; Rubella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Rubella
Most Recent Events
- 29 Jan 2020 Biological E.Limited completes a phase II/III trial in Measles and Rubella (Prevention, In infants) in India (SC) (CTRI2016-07-007109)
- 27 Sep 2019 Launched for Measles (Prevention) in India (SC) prior to September 2019 (Biological E Limited website, September 2019)
- 27 Sep 2019 Launched for Rubella (Prevention) in India (SC) prior to September 2019 (Biological E Limited website, September 2019)